Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Afrezza vs Insulin Aspart in T2DM (MKC-TI-162)
NCT01196104Phase 3Terminated
- Sponsor
- MannKind
- Start
- Sep 2010
- Primary completion
- Aug 2011
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of TI-Inhalation Powder B in type 2 diabetes mellitus (T2DM), sponsored by MannKind. Started Sep 2010; status: terminated.
02
Drugs
TI-Inhalation Powder B
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01196104.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01196104.